GRAMD1B and lung disorder: Additionally, LAmB shows non-inferior efficacy to AMB deoxycholate for treatment of high fungal burden cases, such as disseminated cryptococcosis or severe pulmonary disease (Jarvis et al., 2022; Kimuda et al., 2025).